CRISPR Therapeutics AG
NASDAQ:CRSP
Income Statement
Earnings Waterfall
CRISPR Therapeutics AG
Revenue
|
371.2m
USD
|
Operating Expenses
|
-593.7m
USD
|
Operating Income
|
-222.5m
USD
|
Other Expenses
|
68.9m
USD
|
Net Income
|
-153.6m
USD
|
Income Statement
CRISPR Therapeutics AG
Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
1
+250%
|
2
+114%
|
3
+100%
|
5
+73%
|
7
+40%
|
10
+38%
|
11
+9%
|
41
+273%
|
40
-3%
|
37
-6%
|
35
-5%
|
3
-91%
|
2
-32%
|
1
-38%
|
213
+16 254%
|
290
+36%
|
289
0%
|
289
0%
|
77
-73%
|
1
-99%
|
1
+43%
|
902
+90 070%
|
902
+0%
|
915
+1%
|
915
+0%
|
15
-98%
|
14
-5%
|
1
-91%
|
100
+8 258%
|
170
+70%
|
170
0%
|
371
+118%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||
Operating Expenses |
(26)
|
(34)
|
(48)
|
(58)
|
(73)
|
(85)
|
(92)
|
(102)
|
(106)
|
(111)
|
(124)
|
(148)
|
(162)
|
(183)
|
(199)
|
(222)
|
(243)
|
(268)
|
(293)
|
(313)
|
(355)
|
(396)
|
(454)
|
(491)
|
(541)
|
(603)
|
(649)
|
(701)
|
(674)
|
(662)
|
(644)
|
(594)
|
(594)
|
|
Selling, General & Administrative |
(13)
|
(17)
|
(24)
|
(25)
|
(31)
|
(34)
|
(33)
|
(37)
|
(36)
|
(36)
|
(41)
|
(43)
|
(48)
|
(54)
|
(57)
|
(63)
|
(64)
|
(68)
|
(74)
|
(80)
|
(88)
|
(93)
|
(102)
|
(105)
|
(103)
|
(137)
|
(167)
|
(209)
|
(213)
|
(219)
|
(222)
|
(198)
|
(206)
|
|
Research & Development |
(13)
|
(17)
|
(25)
|
(33)
|
(42)
|
(51)
|
(60)
|
(65)
|
(70)
|
(74)
|
(83)
|
(105)
|
(114)
|
(128)
|
(142)
|
(159)
|
(179)
|
(200)
|
(220)
|
(233)
|
(267)
|
(303)
|
(352)
|
(387)
|
(439)
|
(466)
|
(481)
|
(493)
|
(462)
|
(443)
|
(422)
|
(396)
|
(387)
|
|
Operating Income |
(26)
N/A
|
(34)
-31%
|
(47)
-39%
|
(55)
-18%
|
(68)
-24%
|
(77)
-13%
|
(82)
-6%
|
(91)
-11%
|
(65)
+29%
|
(71)
-10%
|
(87)
-23%
|
(113)
-30%
|
(159)
-41%
|
(180)
-13%
|
(198)
-10%
|
(9)
+95%
|
47
N/A
|
22
-54%
|
(4)
N/A
|
(236)
-5 649%
|
(354)
-50%
|
(395)
-12%
|
448
N/A
|
412
-8%
|
374
-9%
|
312
-16%
|
(634)
N/A
|
(687)
-8%
|
(673)
+2%
|
(562)
+17%
|
(474)
+16%
|
(424)
+11%
|
(223)
+47%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||
Interest Income Expense |
(0)
|
(8)
|
(9)
|
(9)
|
(45)
|
(37)
|
(37)
|
(37)
|
(2)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(6)
|
(6)
|
(4)
|
(3)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Non-Reccuring Items |
0
|
12
|
12
|
12
|
12
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
(0)
|
0
|
(0)
|
79
|
79
|
78
|
78
|
(0)
|
(0)
|
0
|
0
|
(1)
|
0
|
2
|
5
|
26
|
29
|
28
|
25
|
6
|
4
|
4
|
5
|
6
|
5
|
7
|
13
|
23
|
35
|
50
|
63
|
72
|
|
Pre-Tax Income |
(26)
N/A
|
(30)
-18%
|
(44)
-45%
|
(53)
-19%
|
(23)
+57%
|
(36)
-57%
|
(40)
-13%
|
(50)
-23%
|
(67)
-34%
|
(74)
-11%
|
(90)
-22%
|
(117)
-30%
|
(164)
-41%
|
(185)
-12%
|
(200)
-8%
|
(11)
+95%
|
67
N/A
|
46
-31%
|
21
-56%
|
(210)
N/A
|
(348)
-65%
|
(391)
-12%
|
451
N/A
|
416
-8%
|
380
-9%
|
317
-17%
|
(627)
N/A
|
(674)
-8%
|
(651)
+3%
|
(527)
+19%
|
(424)
+20%
|
(360)
+15%
|
(151)
+58%
|
|
Net Income | ||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(5)
|
(4)
|
(2)
|
(5)
|
(7)
|
(7)
|
0
|
3
|
8
|
7
|
(3)
|
|
Income from Continuing Operations |
(26)
|
(31)
|
(44)
|
(53)
|
(23)
|
(36)
|
(41)
|
(51)
|
(68)
|
(75)
|
(91)
|
(117)
|
(165)
|
(185)
|
(200)
|
(11)
|
67
|
46
|
20
|
(211)
|
(349)
|
(392)
|
447
|
412
|
378
|
312
|
(633)
|
(681)
|
(650)
|
(524)
|
(416)
|
(354)
|
(154)
|
|
Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Net Income (Common) |
(26)
N/A
|
(31)
-20%
|
(44)
-44%
|
(53)
-19%
|
(23)
+56%
|
(36)
-56%
|
(41)
-14%
|
(51)
-24%
|
(68)
-33%
|
(75)
-10%
|
(91)
-21%
|
(117)
-28%
|
(165)
-41%
|
(185)
-12%
|
(200)
-8%
|
(11)
+94%
|
67
N/A
|
46
-32%
|
20
-57%
|
(211)
N/A
|
(349)
-65%
|
(392)
-12%
|
447
N/A
|
412
-8%
|
378
-8%
|
312
-18%
|
(633)
N/A
|
(681)
-7%
|
(650)
+4%
|
(524)
+19%
|
(416)
+21%
|
(354)
+15%
|
(154)
+57%
|
|
EPS (Diluted) |
-0.64
N/A
|
-0.77
-20%
|
-1.11
-44%
|
-1.32
-19%
|
-1.89
-43%
|
-0.91
+52%
|
-1.03
-13%
|
-1.28
-24%
|
-1.71
-34%
|
-1.63
+5%
|
-1.95
-20%
|
-2.47
-27%
|
-3.44
-39%
|
-3.55
-3%
|
-3.76
-6%
|
-0.19
+95%
|
1.17
N/A
|
0.75
-36%
|
0.31
-59%
|
-3.01
N/A
|
-5.29
-76%
|
-5.23
+1%
|
5.55
N/A
|
5.39
-3%
|
4.7
-13%
|
4.04
-14%
|
-8.17
N/A
|
-8.72
-7%
|
-8.36
+4%
|
-6.65
+20%
|
-5.25
+21%
|
-4.47
+15%
|
-1.94
+57%
|